Incomplete Follow-up of Hemoglobinopathy Carriers Identified by Newborn Screening Despite Reporting in Electronic Medical Records

被引:3
|
作者
Burney, Mara [2 ]
Schunk, Kelly [1 ]
Oundjian, Nelly J. [1 ]
Younge, Richard G. [3 ]
McCord, Mary [1 ]
Green, Nancy S. [1 ]
机构
[1] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA
[2] Columbia Univ, Med Ctr, Sch Nursing, New York, NY 10032 USA
[3] Columbia Univ, Med Ctr, Ctr Family & Community Med, New York, NY 10032 USA
关键词
infant health; screening; sickle cell disease; electronic medical record; SICKLE-CELL-DISEASE; COMMUNICATION; CARE;
D O I
10.1016/S0027-9684(15)30440-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Has the recent availability of newborn hemoglobinopathy screening results within patient electronic medical records (EMR) of birth hospitals facilitated follow-up by primary care pediatric providers? Methods: An online survey of all 137 primary care pediatric providers at a New York City academic medical center was conducted in 2008-2009 to assess practices for hemoglobinapathy trait follow-up. Physicians were resurveyed 1 year later, following educational outreach and a letter of instruction underscoring the availability of screening results in the EMR. All 62 primary care pediatricians were surveyed at a nearby city hospital for comparison. Results: Overall response rate for the initial survey at the teaching hospital was 58% for pediatricians (N = 57) and family physicians (N = 23), and 50% for pediatricians at the city hospital (N = 31). Despite high prevalence of hemoglobinopathies in the population served and screening results in EMRs, only 46.2% of providers surveyed at the academic center reported routinely checking results of their infant patients: 38.6% of pediatricians and 66.7% of family practitioners. Some respondents were unaware that results are available in the EMR. The proportion of providers checking screening results was not significantly affected by educational intervention (N = 40). Provision of recommended follow-up for a positive trait result was modestly improved, especially in referring families for genetic counseling (25% to 50%, p <.01). In contrast, most pediatricians (83%) at the city hospital routinely check and perform follow-up. Conclusion: Despite access to results in the EMR and targeted educational outreach, follow-up of hemoglobinopathy screening by primary care varies widely across clinical sites.
引用
收藏
页码:852 / 862
页数:11
相关论文
共 38 条
  • [31] Follow-up and monitoring programme in children identified in early-stage type 1 diabetes during screening in the general population of Italy
    Cherubini, Valentino
    Mozzillo, Enza
    Iafusco, Dario
    Bonfanti, Riccardo
    Ripoli, Carlo
    Pricci, Flavia
    Vincentini, Olimpia
    Agrimi, Umberto
    Silano, Marco
    Ulivi, Francesca
    D'Avino, Antonio
    Lampasona, Vito
    Bosi, Emanuele
    DIABETES OBESITY & METABOLISM, 2024, 26 (10) : 4197 - 4202
  • [32] 20-Year Follow-up Study of Celiac Patients Identified in a Mass School Screening: Compliance to Gluten-Free Diet and Autoimmunity
    Cozzi, Giorgio
    Gabbana, Eleonora
    Zanchi, Chiara
    Giudici, Fabiola
    De Leo, Luigina
    Ziberna, Fabiana
    Bramuzzo, Matteo
    Di Leo, Grazia
    Not, Tarcisio
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (01) : 91 - 95
  • [33] Societal costs of permanent childhood hearing loss at teen age: a cross-sectional cohort follow-up study of universal newborn hearing screening
    Chorozoglou, Maria
    Mahon, Merle
    Pimperton, Hannah
    Worsfold, Sarah
    Kennedy, Colin R.
    BMJ PAEDIATRICS OPEN, 2018, 2 (01)
  • [34] Screening in asymptomatic SDHx mutation carriers: added value of 18F-FDG PET/CT at initial diagnosis and 1-year follow-up
    C. Lepoutre-Lussey
    C. Caramella
    F. Bidault
    D. Déandreis
    A. Berdelou
    A. Al Ghuzlan
    D. Hartl
    I. Borget
    A.-P. Gimenez-Roqueplo
    F. Dumont
    F. Deschamps
    C. Nascimento
    J. Lumbroso
    M. Guillaud Bataille
    M. Schlumberger
    E. Baudin
    S. Leboulleux
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 868 - 876
  • [35] Screening in asymptomatic SDHx mutation carriers: added value of 18F-FDG PET/CT at initial diagnosis and 1-year follow-up
    Lepoutre-Lussey, C.
    Caramella, C.
    Bidault, F.
    Deandreis, D.
    Berdelou, A.
    Al Ghuzlan, A.
    Hartl, D.
    Borget, I.
    Gimenez-Roqueplo, A. -P.
    Dumont, F.
    Deschamps, F.
    Nascimento, C.
    Lumbroso, J.
    Bataille, M. Guillaud
    Schlumberger, M.
    Baudin, E.
    Leboulleux, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (06) : 868 - 876
  • [36] What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children
    Hinton, Cynthia F.
    Feuchtbaum, Lisa
    Kus, Christopher A.
    Kemper, Alex R.
    Berry, Susan A.
    Levy-Fisch, Jill
    Luedtke, Julie
    Kaye, Celia
    Boyle, Coleen A.
    GENETICS IN MEDICINE, 2011, 13 (10) : 861 - 865
  • [37] HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark
    M. V. Skriver
    K. Borch-Johnsen
    T. Lauritzen
    A. Sandbaek
    Diabetologia, 2010, 53 : 2328 - 2333
  • [38] HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark
    Skriver, M. V.
    Borch-Johnsen, K.
    Lauritzen, T.
    Sandbaek, A.
    DIABETOLOGIA, 2010, 53 (11) : 2328 - 2333